We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWAND.L Regulatory News (WAND)

  • There is currently no data for WAND

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Dealing

25 May 2017 07:00

RNS Number : 1666G
WANdisco Plc
25 May 2017
 

25 May 2017

 

WANdisco plc

("WANdisco" or the "Company")

 

Director Dealing

 

Charitable donation of shares to the University of Texas at Austin

by Dr Yeturu Aahlad, Co-founder of WANdisco

 

WANdisco (LSE: WAND), the world leader in Active Data Replication™, announces that Dr Yeturu Aahlad, Chief Scientist, Inventor and Co-founder of WANdisco has made a charitable donation of 50,000 ordinary shares, for nil consideration, to the James C. Browne Graduate Fellowship Fund (the "Fund") at the University of Texas at Austin, Department of Computer Science.

 

The Fund was set up in the name of Dr James C. Browne, one of the founding members of the Department of Computer Science, to directly support graduate students for educational and research success.

 

Dr Yeturu Aahlad, Chief Scientist, Inventor and Co-founder of WANdisco, commented:

 

"The Department of Computer Science at the University of Texas at Austin is one of the top graduate programs in the country. I was lucky enough to have Dr Browne as my PhD supervisor - his teaching laid the foundations for my work in distributed computing, ultimately culminating in the invention of WANdisco Fusion.

 

"I have donated these shares for the department to use as it sees fit. I hope the donation will benefit young academics, help them collaborate on invaluable research and allow them to further progress their careers and pursue their passions in computer science."

 

Following this donation, Dr Aahlad is beneficially interested in 2,775,021 shares in the Company, representing 7.4% of the Company's issued share capital.

 

 

For further information, please contact:

 

WANdisco plc

via Vigo Communications

David Richards, Chief Executive Officer and Interim Chairman

Erik Miller, Chief Financial Officer

Vigo Communications

+44 (0)207 830 9700

Jeremy Garcia / Fiona Henson / Antonia Pollock

www.vigocomms.com

Stifel (Joint Broker and Nomad)

+44 (0)207 710 7600

Fred Walsh / Neil Shah / Ben Maddison / Rajpal Padam

UBS (Joint Broker)

Rahul Luthra / Sandip Dhillon

+44 (0)207 567 8000

 

 

About WANdisco

WANdisco is the world leader in Active Data Replication™. Its patented WANdisco Fusion technology enables the replication of continuously changing data to the cloud and on-premises data centers with guaranteed consistency, no downtime and no business disruption. It also allows distributed development teams to collaborate as if they are all working in one location. WANdisco has an OEM with IBM as well partnerships with Amazon Web Services, Cisco, Google Cloud, Hewlett Packard Enterprise, Microsoft Azure, and Oracle to resell its patented technology. WANdisco also works directly with Fortune 1000 companies around the world to ensure their data gives them the real insight they need.

 

For additional information, please visit www.wandisco.com.

 

 

About the James C. Browne Graduate Fellowship Fund

Dr James C. Browne is the last of the University of Texas at Austin Computer Science founding faculty members still active with the department. He published around 500 papers over his 50-year research career and served as supervisor or co-supervisor for the graduate studies of 60 Ph.D. students and 65 master's degree students. In honour of Dr Browne's 65th birthday the James C. Browne Graduate Fellowship was established by the Board of Regents of the University of Texas System on April 6, 2000, for the benefit of the College of Natural Sciences. The gifts received have allowed two graduate fellowships to be awarded each year since its founding. A gift made to the fund will promote continued growth and academic strengthening of the best and brightest minds in the field of parallel programming, whilst ensuring that graduate students in computer science at the University have access to all the financial resources they need to pursue their studies.

 

For additional information, please visit http://endowments.giving.utexas.edu/page/browne-james-grad-flshp/3274/.

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Dr Yeturu Aahlad

 

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Scientist, Inventor and Co-founder

b)

 

Initial notification /Amendment

 

Initial

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

WANdisco plc

b)

 

LEI

 

N/A

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 10 pence each

Identification code

JE00BYPG6G89

b)

 

Nature of the transaction

 

Disposal of shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

0 pence

 

50,000

d)

 

Aggregated information

- Aggregated volume

N/A

- Price

N/A

e)

 

Date of the transaction

 

24 May

f)

 

Place of the transaction

 

London Stock Exchange

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHPGUPUAUPMGMC
Date   Source Headline
4th Oct 20237:00 amRNSWANdisco plc rebrands as Cirata plc
22nd Sep 20236:24 pmRNSHolding(s) in Company
11th Sep 20237:00 amRNSInterim results
7th Sep 20233:30 pmRNSNotice of Results
30th Aug 20236:04 pmRNSResult of Annual General Meeting
18th Aug 20236:05 pmRNSBlock Admission Notification
16th Aug 20238:07 amRNSGM Signs Multi-Project Contract with WANdisco
31st Jul 20237:00 amRNSHolding(s) in Company
28th Jul 20233:25 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSBoard Changes
25th Jul 20237:30 amRNSRestoration - WANdisco plc
25th Jul 20237:00 amRNSConfirmation of Exchange Rate
24th Jul 202310:45 amRNSResult of GM
17th Jul 20235:00 pmRNSPosting of Annual Report and Accounts
12th Jul 20231:45 pmRNSPublication of Annual Report and Accounts
11th Jul 20237:00 amRNSContract Win
10th Jul 20237:00 amRNSContract Renewal
7th Jul 20237:00 amRNSConfirmation of Fundraise
5th Jul 20236:29 pmRNSPublication of Notice of General Meeting
5th Jul 202311:30 amRNSUpdate to Fundraise Timetable
4th Jul 20237:00 amRNSResult of Fundraising
3rd Jul 202312:00 pmRNSLaunch of Fundraise
29th Jun 20237:00 amRNSPreliminary Unaudited Results FY22
28th Jun 202311:51 amRNSUpdate on Timing of Results and Equity Issue
26th Jun 20233:30 pmRNSTurnaround Plan Momentum
26th Jun 20237:00 amRNSWANdisco Signs New Agreement with Accenture
15th Jun 20239:46 amRNSFCA investigation timeline update
9th Jun 20237:00 amRNSSuccessful Shareholder General Meeting Next Steps
6th Jun 20233:49 pmRNSResult of General Meeting
19th May 20236:22 pmRNSPublication of Circular and Notice of GM
19th May 20236:04 pmRNSBoard Change
15th May 20237:00 amRNSExploring Funding Options
9th May 20235:30 pmRNSWANdisco
9th May 20237:00 amRNSAppointment of Interim Chief Executive
4th May 20237:00 amRNSOrganisation Update
28th Apr 20237:00 amRNSIndependent Investigation Update
20th Apr 20237:00 amRNSFCA Investigation
5th Apr 20237:00 amRNSExecutive Chair Appointment Confirmation
4th Apr 20237:00 amRNSContract Renewals
3rd Apr 20237:00 amRNSBoard Change and Investigation Update
22nd Mar 20237:00 amRNSAppointment of Interim Chair
10th Mar 20239:31 amRNSIndependent Investigation Appointment
9th Mar 20237:30 amRNSSuspension - WANdisco plc
9th Mar 20237:00 amRNSTrading Revision
7th Mar 20237:00 amRNSAppointment of Joint Broker
6th Mar 20237:00 amRNSResponse to press speculation
1st Mar 20238:16 amRNSTotal Voting Rights
1st Feb 20234:05 pmRNSTotal Voting Rights
24th Jan 20237:00 amRNS$9m industrial and consumer goods contract win
11th Jan 20237:00 amRNSFY22 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.